Table: Cosmos Pharmaceutical -Q1 group results

Cosmos Pharmaceutical

12/10/2017 07:00

Oct 12 (Reuters)-  
             Cosmos Pharmaceutical Corp.  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 3 months ended      3 months ended       Year to  
                Aug 31, 2017        Aug 31, 2016     May 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales            138.73              126.58           550.00     
                 (+9.6 pct)          (+14.7 pct)      (+9.4 pct)   
  Operating          6.26                6.80            22.30     
                 (-8.0 pct)          (+36.1 pct)      (+0.3 pct)   
  Recurring          6.86                7.29            24.60     
                 (-5.9 pct)          (+32.3 pct)      (+0.0 pct)   
  Net                4.64                4.61            17.00     
                 (+0.5 pct)          (+36.9 pct)      (-6.7 pct)   
  EPS            234.29 yen          233.08 yen       858.60 yen   
  Ann Div                             80.00 yen        90.00 yen   
  -Q2 div                             35.00 yen        45.00 yen   
  -Q4 div                             45.00 yen        45.00 yen   
   
  NOTE - Cosmos Pharmaceutical Corp..  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T  
  ((Tokyo Headline News Desk +813 6441 1812))